Trial Profile
A Retrospective Cohort Study Investigating Bedaquiline and Linezolid for the Operational Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in a High Burden HIV Setting
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2021
Price :
$35
*
At a glance
- Drugs Bedaquiline (Primary) ; Linezolid (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms BLIX
- 20 May 2020 Results (N=116 bedaquiline-linezolid cohort + 80 from historical cohort), comparing rates of adverse events in DR-TB HIV patients receiving bedaquiline-linezolid with ART compared to previous regimens, presented at the 116th International Conference of the American Thoracic Society
- 13 Jul 2017 New trial record
- 24 May 2017 Results (n=153) presented at the 113th International Conference of the American Thoracic Society.